{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:03:34Z","timestamp":1782421414922,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bvth.2026.100155","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:27:00Z","timestamp":1773163620000},"page":"100155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["An angiopoietin-2 vaccine improves arteriovenous malformation pathology in hereditary hemorrhagic telangiectasia mice"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6254-5759","authenticated-orcid":false,"given":"Sima","family":"Qutaina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-7196","authenticated-orcid":false,"given":"Caterina","family":"Ivaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2626-6160","authenticated-orcid":false,"given":"Santiago","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8983-1497","authenticated-orcid":false,"given":"Philippe","family":"Marambaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bvth.2026.100155_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin","year":"2010","journal-title":"Blood Rev"},{"issue":"5","key":"10.1016\/j.bvth.2026.100155_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.124.005061","article-title":"Hereditary hemorrhagic telangiectasia prevalence estimates calculated from GnomAD allele frequencies of predicted pathogenic variants in ENG and ACVRL1","volume":"18","author":"Anzell","year":"2025","journal-title":"Circ Genom Precis Med"},{"issue":"12","key":"10.1016\/j.bvth.2026.100155_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/M20-1443","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"173","author":"Faughnan","year":"2020","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.bvth.2026.100155_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-024-00585-z","article-title":"Hereditary haemorrhagic telangiectasia","volume":"11","author":"Hermann","year":"2025","journal-title":"Nat Rev Dis Primers"},{"issue":"14","key":"10.1016\/j.bvth.2026.100155_bib5","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1182\/bloodadvances.2022007748","article-title":"Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument","volume":"6","author":"Kasthuri","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.bvth.2026.100155_bib6","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/ajh.27756","article-title":"Characterizing the healthcare utilization and costs of hereditary hemorrhagic telangiectasia","volume":"100","author":"Al-Samkari","year":"2025","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.bvth.2026.100155_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/path.4844","article-title":"The pathobiology of vascular malformations: insights from human and model organism genetics","volume":"241","author":"Wetzel-Strong","year":"2017","journal-title":"J Pathol"},{"issue":"4","key":"10.1016\/j.bvth.2026.100155_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176379","article-title":"Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances","volume":"134","author":"Al Tabosh","year":"2024","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.bvth.2026.100155_bib9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.yexcr.2013.03.011","article-title":"Angiopoietin signaling in the vasculature","volume":"319","author":"Eklund","year":"2013","journal-title":"Exp Cell Res"},{"issue":"5","key":"10.1016\/j.bvth.2026.100155_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology","volume":"8","author":"Akwii","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bvth.2026.100155_bib11","doi-asserted-by":"crossref","first-page":"37366","DOI":"10.1038\/srep37366","article-title":"A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10","volume":"5","author":"Ruiz","year":"2016","journal-title":"Sci Rep"},{"issue":"17","key":"10.1016\/j.bvth.2026.100155_bib12","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1161\/CIRCULATIONAHA.118.036952","article-title":"Angiopoietin-2 inhibition rescues arteriovenous malformation in a Smad4 hereditary hemorrhagic telangiectasia mouse model","volume":"139","author":"Crist","year":"2019","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.bvth.2026.100155_bib13","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/ATVBAHA.123.319385","article-title":"ANG2 blockade diminishes proangiogenic cerebrovascular defects associated with models of hereditary hemorrhagic telangiectasia","volume":"43","author":"Zhou","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.bvth.2026.100155_bib14","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","article-title":"Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis","volume":"97","author":"Oh","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bvth.2026.100155_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10456-013-9383-4","article-title":"Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment","volume":"17","author":"Ardelean","year":"2014","journal-title":"Angiogenesis"},{"key":"10.1016\/j.bvth.2026.100155_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2119\/molmed.2016.00218","article-title":"A modification-specific peptide-based immunization approach using CRM197 carrier protein: development of a selective vaccine against pyroglutamate A\u03b2 peptides","volume":"22","author":"Vingtdeux","year":"2017","journal-title":"Mol Med"},{"issue":"11","key":"10.1016\/j.bvth.2026.100155_bib17","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s44161-024-00550-9","article-title":"CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia","volume":"3","author":"Dinakaran","year":"2024","journal-title":"Nat Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.bvth.2026.100155_bib18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1172\/JCI127425","article-title":"Correcting Smad1\/5\/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models","volume":"130","author":"Ruiz","year":"2020","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.bvth.2026.100155_bib19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nsmb1101","article-title":"Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex","volume":"13","author":"Barton","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bvth.2026.100155_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.973964","article-title":"An update on preclinical models of hereditary haemorrhagic telangiectasia: insights into disease mechanisms","volume":"9","author":"Arthur","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.bvth.2026.100155_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13650","article-title":"PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia","volume":"7","author":"Ola","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bvth.2026.100155_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10456-024-09957-1","article-title":"Inhibition of angiopoietin-2 rescues sporadic brain arteriovenous malformations by reducing pericyte loss","volume":"28","author":"Tu","year":"2024","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.bvth.2026.100155_bib23","first-page":"233","article-title":"The global landscape of approved antibody therapies","volume":"5","author":"Lyu","year":"2022","journal-title":"Antib Ther"},{"issue":"4","key":"10.1016\/j.bvth.2026.100155_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrd3003","article-title":"The safety and side effects of monoclonal antibodies","volume":"9","author":"Hansel","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.bvth.2026.100155_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s11899-019-00542-8","article-title":"Mechanisms of resistance to monoclonal antibodies (mAbs) in lymphoid malignancies","volume":"14","author":"Torka","year":"2019","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.bvth.2026.100155_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9749363","article-title":"Development of peptide-based vaccines for cancer","volume":"2022","author":"Abd-Aziz","year":"2022","journal-title":"J Oncol"},{"issue":"1","key":"10.1016\/j.bvth.2026.100155_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett"},{"issue":"5","key":"10.1016\/j.bvth.2026.100155_bib28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/ATVBAHA.109.185165","article-title":"Mechanisms of vessel branching: filopodia on endothelial tip cells lead the way","volume":"29","author":"De Smet","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"10.1016\/j.bvth.2026.100155_bib29","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1093\/hmg\/ddx358","article-title":"Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology","volume":"26","author":"Ruiz","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"13","key":"10.1016\/j.bvth.2026.100155_bib30","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/hmg\/ddm069","article-title":"Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia","volume":"16","author":"Fernandez-L","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"24","key":"10.1016\/j.bvth.2026.100155_bib31","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3390\/diagnostics14242783","article-title":"Diagnostic and prognostic value of angiogenic status in hereditary hemorrhagic telangiectasia","volume":"14","author":"Jaimes-D\u00edaz","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"7-8","key":"10.1016\/j.bvth.2026.100155_bib32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.cca.2009.12.023","article-title":"Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT)","volume":"411","author":"Ojeda-Fernandez","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.bvth.2026.100155_bib33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s13023-021-02009-7","article-title":"Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations","volume":"16","author":"Wetzel-Strong","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"pt 4","key":"10.1016\/j.bvth.2026.100155_bib34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1242\/jcs.01653","article-title":"The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism","volume":"118","author":"Scharpfenecker","year":"2005","journal-title":"J Cell Sci"},{"issue":"10","key":"10.1016\/j.bvth.2026.100155_bib35","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1161\/01.ATV.0000140819.81839.0e","article-title":"Expression of angiopoietin-2 in endothelial cells is controlled by positive and negative regulatory promoter elements","volume":"24","author":"Hegen","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bvth.2026.100155_bib36","article-title":"Decreased endothelial cell retinoic acid signaling accelerates progression of single ventricle pulmonary arteriovenous malformations","author":"Rousseau","year":"2025","journal-title":"bioRxiv"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327226000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:19:50Z","timestamp":1779895190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327226000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2950327226000203"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100155","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An angiopoietin-2 vaccine improves arteriovenous malformation pathology in hereditary hemorrhagic telangiectasia mice","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2026.100155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100155"}}